FD&C RED NO. 3
Molecular Excipient
| Mwt. | LogP | HBD | HBA | PSA | RB | CSP3 |
|---|---|---|---|---|---|---|
| 836.0 | 6.4 | 2 | 4 | 88.0 | 2 | 0.0 |
- CAS
- 49746103
- UNII
- PN2ZH5LOQY
- SYNONYMS
-
- ZINC ID(s)
- Availability
- Present in 39 ZINC catalogs
Known Active Genes
This compound has been observed to have activity at 10μM or less against the following gene(s).
| Name | Description | Classification |
|---|---|---|
| CHAT | Choline O-acetyltransferase | Enzyme / Enzyme-Other |
Clinical Trials
This compound has not been in (or located in) any clinical trials (per clinicaltrials.gov).
(Browse) Purchasable Analogs in ZINC
Functions of Fd&c Red No. 3
| Dye - Dye |
Dosages
| Route | Formulation | Per Unit Dose |
|---|---|---|
| Oral | Capsule | 1.69MG |
| Oral | Capsule (Immed./comp. Release) | 0.001MG |
| Oral | Capsule, Extended Release | 0.05MG |
| Oral | Capsule, Hard Gelatin | |
| Oral | Capsule, Soft Gelatin | 0.22MG |
| Oral | Capsule, Sustained Action | 0.3MG |
| Oral | Drops | 0.01% |
| Oral | Granule | 0.25MG |
| Oral | Powder, For Oral Suspension | 0.01% |
| Oral | Powder, For Solution | |
| Oral | Powder, For Suspension | 0.04% |
| Oral | Solution, Elixir | 0.001% |
| Oral | Suspension | 0.02% |
| Oral | Syrup | 0.003% |
| Oral | Tablet | 2.2MG |
| Oral | Tablet (Immed./comp. Release), Uncoated, Chewable | 0.05MG |
| Oral | Tablet, Coated | 0.5MG |
| Oral | Tablet, Delayed Action, Enteric Coated | 0.005MG |
| Oral | Tablet, Extended Release | 0.03MG |
| Oral | Tablet, Film Coated | 0.004MG |
| Oral | Tablet, Sustained Action | |
| Oral | Tablet, Sustained Action, Coated | |
| Oral-20 | Tablet | |
| Oral-21 | Tablet | 0.003MG |
| Oral-28 | Tablet |